MeiShiMD

Family Medicine • Iowa City, IA

Physician

Join to view full profile

Are you Dr. Shi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 11 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1067 Ryan Ct
Iowa City, IA 52246
Phone+1 319-688-7999

Fax+1 319-688-7096
Is this information wrong?

Summary

Dr. Mei Shi, MD is a board certified family physician in Iowa City, Iowa. She is currently licensed to practice medicine in Iowa and Washington. She is affiliated with St. Clare Hospital and MultiCare Tacoma General Hospital.

Education & Training

Siouxland Medical Education FoundationResidency, Family Medicine, 2010 - 2013
West China University of Medical SciencesClass of 1983

Certifications & Licensure

WA State Medical License 2019 - 2024
IA State Medical License 2010 - 2021
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Intergy EHR, Vitera Healthcare Solutions, LLC, 2013

Clinical Trials

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer Start of enrollment: 2009 Oct 01
Unknown status
Phase 3
Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma Start of enrollment: 2010 Sep 01
Unknown status
Phase 2
Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer Start of enrollment: 2011 Oct 13
Active, not recruiting
Phase 2, Phase 3
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer Start of enrollment: 2016 Feb 01
Recruiting
Phase 3
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer Start of enrollment: 2015 Sep 01
Unknown status
Phase 2
Biomarkers and Functional Imaging in Predicting Response of Esophageal Cancer Start of enrollment: 2016 May 01
Unknown status
Join now to see all

Publications & Presentations

PubMed

α-Adrenergic receptor-PKC-Pyk2-Src signaling boosts L-type Cachannel Ca1.2 activity and long-term potentiation in rodents.
Kwun Nok Mimi Man, Peter Bartels, Peter B Henderson, Karam Kim, Mei Shi, Mingxu Zhang, Sheng-Yang Ho, Madeline Nieves-Cintron, Manuel F Navedo, Mary C Horne, Johannes ...> ;Elife. 2023 Jun 20

Press Mentions

[Textual Research on Lost Articles in Mei Shi Fang]January 28th, 2020

Hospital Affiliations

St. Clare HospitalLakewood, Washington
MultiCare Tacoma General HospitalTacoma, Washington